Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures
The number and targets of immunotherapies are rapidly evolving resulting in challenges with creating, up-to-date and consistent TB infection screening recommendations. Inconsistent recommendations in clinical resources may contribute to gaps in TB preventive care. Harmonized recommendations and additional epidemiologic studies of TB disease risk with the use of these agents are needed.
Authors
- Daniel J. Minter (ORCID: https://orcid.org/0000-0002-4487-934X)
- John D. Szumowski (ORCID: https://orcid.org/0000-0002-0287-9704)
- Jorge D. Salazar (ORCID: https://orcid.org/0000-0002-7888-4198)
- Jinoos Yazdany (ORCID: https://orcid.org/0000-0002-3508-4094)
- Allison L. Phillips (ORCID: https://orcid.org/0000-0002-0192-5190)
- Haiyan Ramírez Batlle (ORCID: https://orcid.org/0000-0003-2195-587X)
- Anand Habib (ORCID: https://orcid.org/0000-0002-6629-8749)
- Gustavo E. Velásquez (ORCID: https://orcid.org/0000-0003-1438-0692)
- Eric T. Roberts (ORCID: https://orcid.org/0009-0005-8435-8994)
- Janice K. Louie (ORCID: https://orcid.org/0000-0001-6568-5213)
- Annie Kim
- J. Ernst (ORCID: https://orcid.org/0000-0001-9951-6207)
- Matthew Murrill (ORCID: https://orcid.org/0000-0001-7567-7727)
Institutions
- San Francisco General Hospital (US)
- University of California, San Francisco (US)
- University of Washington (US)
- University of California System (US)
- San Francisco Department of Public Health (US)
- Global Brain Health Institute (US)
- Global Solutions for Infectious Diseases (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1093/cid/ciaf628
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00